Ethics

Latest News

May 4th 2021

Fostering Human Connection in a Sustainable Virtual World

By Janet Lewis, MD, Beth Mark, MD, MES, Elizabeth Haase, MD

How can psychiatry meet its ethical duty to mitigate climate change while also promoting collegiality at conferences?

May 3rd 2021

Expert Panel Ponders What It Takes To Be an Ethical Psychiatrist

By Paul Gleason, PhD

March 29th 2021

Personal Reflections on Climate Change

By James L. Fleming, MD

March 11th 2021

Whose Turn Should It Be? The Ethics of COVID-19 Vaccine Allocation

By Cynthia M.A. Geppert, MD, PhD, MA, MPH, MSBE, DPS, MSJ

March 11th 2021

Clinician, Patients Take the Fight for Psilocybin To Court

By Leah Kuntz

CME Content

In-Person Event

Southern Florida Psychiatry Conference

November 21-22, 2025

Register now!

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

In-Person + Virtual Event

Real Psychiatry 2026

January 23-24, 2026

Video

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Michael Asbach, DMSc, PA-C; Erin Crown, MHS, PA-C, Psych-CAQ

Video

Optimizing Care for Patients With Tardive Dyskinesia

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

Video

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

A New CME: Continuing Moral Education

ByDamir Huremović, MD, MPP,Jason Goodman, MD,Prince Prabhakar, MD

March 9th 2021

Every phase of the COVID-19 pandemic brings new ethical challenges.

Black Americans’ Distrust of the COVID-19 Vaccine

ByRakin Hoq, MD,Balkozar S. Adam, MD

February 24th 2021

A case for why psychiatrists should discuss the COVID vaccines with their patients.

Ethics

Latest News

CME Content

Southern Florida Psychiatry Conference

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Real Psychiatry 2026

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Optimizing Care for Patients With Tardive Dyskinesia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(Pharmacist Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

A New CME: Continuing Moral Education

Black Americans’ Distrust of the COVID-19 Vaccine

Trending on Psychiatric Times

Lecanemab or Lithium for Alzheimer Disease Dementia? New Data Change Everything

Planned FDA Investigational New Drug Application: SPC-15 for the Treatment of PTSD

Toward a Spiritual Psychiatry Subspecialty

Polypharmacy in Clozapine-Treated Patients: A Retrospective Analysis

Making Chatbots Safe For Suicidal Patients